About
ORI Capital is a premier venture capital firm dedicated to fostering innovation in the biotechnology sector by investing in cutting-edge early-stage companies across the globe. With a keen focus on diagnostics, drug delivery, and therapeutics, ORI Capital aims to combat high-mortality diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions. By leveraging deep industry expertise and strategic partnerships, ORI Capital accelerates the development of breakthrough solutions that have the potential to transform patient outcomes and improve global health. Our commitment to advancing science and supporting visionary entrepreneurs positions ORI Capital at the forefront of the biotech investment landscape.